LALPATHLAB.NS Dr. Lal Path Labs Ltd.
Price history
Price is the daily close from stored Kite history. The other metrics pair that daily price with the company's periodic filings — each fundamental (revenue, EPS, equity…) is held flat at its latest filed value between annual filings, so a ratio steps at each filing and moves daily only through its price term. A metric with no input on file for this company (e.g. EV/EBITDA for a bank, which has no EBIT) is shown as unavailable, never guessed. Share-count-based metrics use the latest diluted share count against split/bonus-adjusted prices.
Technical indicators
ℹ These reflect only the stock's recent price and volume behavior — not the company's fundamentals — and are not a recommendation to buy or sell. Standard published parameters are used throughout (see each chart's own label); a company with too little stored price history for a given indicator's lookback window shows that plainly below rather than a garbage or misleading value.
MACD (12,26,9), Stochastic Oscillator (14,3) and Money Flow Index (14-day) each carry their own published reference lines/bands (20/80 for the oscillator readings) where one is standard. ADX includes +DI/-DI for direction alongside trend strength; a dashed line marks the commonly published 25 "trending market" reading. ATR is shown in raw rupees here; the price/volume preset screen (below, and on the Screener page) reports it as a % of price so it's comparable across stocks at different price levels. Computed from the same stored daily OHLCV history as the price chart above — no new data source.
Delivery volume
| Date | Traded Qty | Delivery Qty | Delivery % |
|---|---|---|---|
| 2026-08-28 | 90724 | 54710 | 60.30% |
| 2026-08-27 | 87929 | 49758 | 56.59% |
| 2026-08-26 | 134265 | 70012 | 52.14% |
| 2026-08-25 | 194732 | 103917 | 53.36% |
| 2026-08-24 | 146775 | 84191 | 57.36% |
| 2026-08-21 | 99702 | 47892 | 48.04% |
| 2026-08-20 | 308167 | 178058 | 57.78% |
| 2026-08-19 | 156564 | 108777 | 69.48% |
| 2026-08-18 | 211640 | 114212 | 53.97% |
| 2026-08-17 | 134988 | 56874 | 42.13% |
| 2026-08-14 | 229786 | 125395 | 54.57% |
| 2026-08-13 | 205127 | 140667 | 68.58% |
| 2026-08-12 | 351481 | 226953 | 64.57% |
| 2026-08-11 | 198678 | 133360 | 67.12% |
| 2026-08-10 | 290743 | 146945 | 50.54% |
| 2026-08-07 | 158460 | 99318 | 62.68% |
| 2026-08-06 | 427191 | 254503 | 59.58% |
| 2026-08-05 | 318039 | 185971 | 58.47% |
| 2026-08-04 | 500180 | 297524 | 59.48% |
| 2026-08-03 | 718505 | 482379 | 67.14% |
Delivery quantity/percentage from the NSE bhavcopy (DELIV_QTY/DELIV_PER) — the share of that day's traded volume that actually settled into a demat account, rather than being squared off intraday. A higher delivery percentage is commonly read as genuine accumulation/distribution rather than speculative same-day trading; this describes recent trading PATTERN, not the company itself, and is not a recommendation to buy or sell. A blank cell is a day NSE itself published no figure for, never a zero. Run python manage.py refresh_delivery_volumes --tickers LALPATHLAB.NS to fetch more history.
Insider trading activity
| Disclosed | Person | Category | Type | Mode | Quantity | Value (₹) | Resulting stake | |
|---|---|---|---|---|---|---|---|---|
| 01 May 2026 | Dr. Lal PathLabs Employees Welfare Trust | Other | Buy | ESOP | 82750 | 94434300 | 0.39% | XBRL |
| 31 Mar 2026 | Rahul Sharma | Director | Sell | Market Sale | 1000 | 1302700 | 0.02% | XBRL |
| 24 Feb 2026 | Dr. Lal PathLabs Employees Welfare Trust | Other | Sell | ESOP | 2024 | 1541996 | 0.35% | XBRL |
| 24 Feb 2026 | Abhishek Aggarwal | Employees/Designated Employees | Buy | ESOP | 1500 | 1539376 | 0.00% | XBRL |
| 19 Feb 2026 | Dr. Lal PathLabs Employees Welfare Trust | Other | Sell | ESOP | 1876 | 670132 | 0.35% | XBRL |
| 11 Feb 2026 | Jitender Sharma | Employees/Designated Employees | Pledge | Pledge Creation | 2470 | 3568903 | 0.00% | XBRL |
| 04 Feb 2026 | Rahul Sharma | Director | Buy | ESOP | 4000 | 622600 | 0.02% | XBRL |
| 31 Dec 2025 | Rahul Sharma | Director | Sell | Market Sale | 2500 | 3657000 | 0.01% | XBRL |
| 31 Dec 2025 | Sanjay Kulshreshtha | Employees/Designated Employees | Buy | ESOP | 250 | 2500 | 0.00% | XBRL |
| 31 Dec 2025 | Sanjay Kulshreshtha | Employees/Designated Employees | Buy | ESOP | 424 | 2120 | 0.00% | XBRL |
| 31 Dec 2025 | Gaurav Sharma | Employees/Designated Employees | Buy | ESOP | 2500 | 2535015 | 0.00% | XBRL |
| 31 Dec 2025 | Dr. Lal PathLabs Employees Welfare Trust | Other | Sell | ESOP | 4424 | 2544635 | 0.35% | XBRL |
| 31 Dec 2025 | Abhishek Aggarwal | Employees/Designated Employees | Sell | Market Sale | 1750 | 2542750 | 0.00% | XBRL |
| 17 Dec 2025 | Dr. Lal PathLabs Employees Welfare Trust | Other | Sell | ESOP | 4350 | 1003526 | 0.35% | XBRL |
| 17 Dec 2025 | Ved Prakash Goel | Key Managerial Personnel | Buy | ESOP | 450 | 4500 | 0.02% | XBRL |
| 17 Dec 2025 | Dr. Seema Narang Kochhar | Employees/Designated Employees | Buy | ESOP | 750 | 7500 | 0.02% | XBRL |
| 17 Dec 2025 | Manoj Kumar Garg | Employees/Designated Employees | Buy | ESOP | 2500 | 25000 | 0.03% | XBRL |
| 05 Dec 2025 | Dr. Lal PathLabs Employees Welfare Trust | Other | Sell | ESOP | 686 | 486873 | 0.35% | XBRL |
| 13 Nov 2025 | Dr. Lal PathLabs Employees Welfare Trust | Other | Sell | ESOP | 3200 | 32000 | 0.36% | XBRL |
| 13 Nov 2025 | Ved Prakash Goel | Key Managerial Personnel | Buy | ESOP | 3200 | 32000 | 0.02% | XBRL |
SEBI PIT (Prohibition of Insider Trading) Regulation 7 disclosures — designated persons (promoters, directors, KMPs, and their immediate relatives) reporting their own dealing in the company's securities, as NSE publishes them. Distinct from the SAST (Regulation 29 substantial-acquisition) filings on the market-wide SAST activity page. Public record only — this is descriptive disclosure data, not a signal, and is not a recommendation to buy or sell. Run python manage.py refresh_insider_trades --tickers LALPATHLAB.NS to fetch more.
Extract this company (financials + ratios + citations): CSV · XLSX
Full statements: Profit & Loss · Balance Sheet · Cash Flow · Compare with 46 peers in Healthcare · Trace Score
Ratios
This is cash paid during the fiscal year, not a per-share rate declared for it (no such element exists in the filing data) — timing can straddle interim/final dividends across years, and pre-FY2020-21 figures may include the since-abolished Dividend Distribution Tax, reading higher than later years for that reason alone.
Growth & earnings trend
Revenue & Profit CAGR
Operating Margin Trend
ROCE Trajectory
Earnings Quality
No persistent gap detected
Net Profit CAGR 28.31% vs CFO CAGR 11.71% over 3.0y (2023-03-31 → 2026-03-31); most recent year: Net Profit +3.63% vs CFO +11.76%
Sector-Relative Percentile (Healthcare)
Quarterly trend
| Metric (to shareholders basis) | Q4 FY2023-24 | Q1 FY2024-25 | Q2 FY2024-25 | Q3 FY2024-25 | Q4 FY2024-25 | Q1 FY2025-26 | Q2 FY2025-26 | Q3 FY2025-26 | Q4 FY2025-26 | Q1 FY2026-27 | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ₹545.40 Cr. | ₹601.90 Cr. | ₹660.20 Cr. | ₹596.70 Cr. | ₹602.60 Cr. | ₹669.80 Cr. | ₹730.60 Cr. | ₹659.80 Cr. | ₹702.70 Cr. | ₹797.70 Cr. | RevenueFromOperations |
| Net Profit | ₹84.50 Cr. incl. minority ₹85.80 Cr. | ₹106.40 Cr. incl. minority ₹107.80 Cr. | ₹129.20 Cr. incl. minority ₹130.80 Cr. | ₹96.70 Cr. incl. minority ₹98.10 Cr. | ₹154.80 Cr. incl. minority ₹155.50 Cr. | ₹132.40 Cr. incl. minority ₹134.00 Cr. | ₹150.60 Cr. incl. minority ₹152.20 Cr. | ₹90.50 Cr. incl. minority ₹91.40 Cr. | ₹131.30 Cr. incl. minority ₹132.20 Cr. | ₹169.50 Cr. incl. minority ₹170.50 Cr. | ProfitOrLossAttributableToOwnersOfParent |
Primary figures are Revenue from Operations and Net Profit attributable to shareholders — the basis the ratios use. Where they differ, the companion Gross revenue (incl. inter-segment) and incl. minority net profit (the totals a news headline usually quotes) are shown beneath, each traceable to its own XBRL element. Quarters shown are however many are actually stored (up to 10) — run python manage.py refresh_quarterly_trend --tickers LALPATHLAB.NS to fetch more.
Source document — income statement (FY2025-26, raw filing line items)
View original filing on NSE ↗ NSE's own filing document, opened in a new tab — StockProof links to it, never stores a copy.
| ProfitOrLossAttributableToOwnersOfParent | 5048000000.0 |
| PaidUpValueOfEquityShareCapital ÷ FaceValueOfEquityShareCapital | 167600000.0 |
Source document — balance sheet (FY2025-26, raw filing line items)
View original filing on NSE ↗ NSE's own filing document, opened in a new tab — StockProof links to it, never stores a copy.
| CurrentAssets | 15666000000.0 |
| CurrentLiabilities | 4507000000.0 |
| EquityAttributableToOwnersOfParent | 25082000000.0 |
| BorrowingsCurrent + BorrowingsNoncurrent | — |